Company intelligence / Profile preview
RepliCel Life Sciences Inc.
Vancouver, British Columbia, Canadareplicel.com ↗
- Ownership
- Private
- Employees
- ~1
- Development stage
- Phase 1
01
Overview
Completed Phase 1 human clinical studies in hair loss due to androgenetic alopecia, aging & sun-damaged skin, and chronic Achilles tendinopathy. Recently completed a randomized, double-blinded, placebo-controlled, dose-finding study in patients with advanced hair loss due to androgenic alopecia.
- Therapeutic areas
- DermatologyRheumatology
- Modalities
- Autologous cell therapies
- Industry
- Biotech
02
Drug pipeline
4 assets3 more assets in the full pipeline.
Request access →03
Partnerships
Shiseido
Beyond the preview
Go deeper on RepliCel Life Sciences Inc..
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on RepliCel Life Sciences Inc..